220 related articles for article (PubMed ID: 38104416)
1. Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia.
Al-Hamaly MA; Cox AH; Haney MG; Zhang W; Arvin EC; Sampathi S; Wimsett M; Liu C; Blackburn JS
Biomed Pharmacother; 2024 Jan; 170():116013. PubMed ID: 38104416
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish Drug Screening Identifies Erlotinib as an Inhibitor of Wnt/β-Catenin Signaling and Self-Renewal in T-cell Acute Lymphoblastic Leukemia.
Al-Hamaly MA; Cox AH; Haney MG; Zhang W; Arvin EC; Sampathi S; Wimsett M; Liu C; Blackburn JS
bioRxiv; 2023 Aug; ():. PubMed ID: 37693603
[TBL] [Abstract][Full Text] [Related]
3. Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/β-catenin signaling pathways.
Karaca B; Bakır E; Yerer MB; Cumaoğlu A; Hamurcu Z; Eken A
J Biochem Mol Toxicol; 2021 Nov; 35(11):e22905. PubMed ID: 34463000
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells.
Lin Y; Higashisaka K; Shintani T; Maki A; Hanamuro S; Haga Y; Maeda S; Tsujino H; Nagano K; Fujio Y; Tsutsumi Y
Sci Rep; 2020 Mar; 10(1):4748. PubMed ID: 32179851
[TBL] [Abstract][Full Text] [Related]
5. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
[TBL] [Abstract][Full Text] [Related]
6. Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells.
Kleszcz R; Frąckowiak M; Dorna D; Paluszczak J
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445628
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition and suppression of the mTOR and Wnt/β-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion.
Kong D; Fan S; Sun L; Chen X; Zhao Y; Zhao L; Guo Z; Li Y
Hematol Oncol; 2021 Apr; 39(2):222-230. PubMed ID: 33300153
[TBL] [Abstract][Full Text] [Related]
8. Revisiting β-Catenin Signaling in T-Cell Development and T-Cell Acute Lymphoblastic Leukemia.
Bigas A; Guillén Y; Schoch L; Arambilet D
Bioessays; 2020 Feb; 42(2):e1900099. PubMed ID: 31854474
[TBL] [Abstract][Full Text] [Related]
9. Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling.
Giambra V; Jenkins CE; Lam SH; Hoofd C; Belmonte M; Wang X; Gusscott S; Gracias D; Weng AP
Blood; 2015 Jun; 125(25):3917-27. PubMed ID: 25934477
[TBL] [Abstract][Full Text] [Related]
10. A zebrafish chemical suppressor screening identifies small molecule inhibitors of the Wnt/β-catenin pathway.
Nishiya N; Oku Y; Kumagai Y; Sato Y; Yamaguchi E; Sasaki A; Shoji M; Ohnishi Y; Okamoto H; Uehara Y
Chem Biol; 2014 Apr; 21(4):530-540. PubMed ID: 24684907
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3 inhibitors induce the canonical WNT/β-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma.
Chen EY; DeRan MT; Ignatius MS; Grandinetti KB; Clagg R; McCarthy KM; Lobbardi RM; Brockmann J; Keller C; Wu X; Langenau DM
Proc Natl Acad Sci U S A; 2014 Apr; 111(14):5349-54. PubMed ID: 24706870
[TBL] [Abstract][Full Text] [Related]
12. Hyper-activation of WNT/β-catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia.
Shao N; Zou J; Li J; Chen F; Dai J; Qu X; Sun X; Ma D; Ji C
Leuk Lymphoma; 2012 Sep; 53(9):1769-78. PubMed ID: 22303878
[TBL] [Abstract][Full Text] [Related]
13. [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
Nishiya N
Yakugaku Zasshi; 2017; 137(2):133-136. PubMed ID: 28154320
[TBL] [Abstract][Full Text] [Related]
14. The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis.
Mahmoudi T; Boj SF; Hatzis P; Li VS; Taouatas N; Vries RG; Teunissen H; Begthel H; Korving J; Mohammed S; Heck AJ; Clevers H
PLoS Biol; 2010 Nov; 8(11):e1000539. PubMed ID: 21103407
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-catenin signaling acts cell-autonomously to promote cardiomyocyte regeneration in the zebrafish heart.
Bertozzi A; Wu CC; Hans S; Brand M; Weidinger G
Dev Biol; 2022 Jan; 481():226-237. PubMed ID: 34748730
[TBL] [Abstract][Full Text] [Related]
16. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
[TBL] [Abstract][Full Text] [Related]
17. The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia.
Chiarini F; Paganelli F; Martelli AM; Evangelisti C
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046053
[TBL] [Abstract][Full Text] [Related]
18. The stem-like Stat3-responsive cells of zebrafish intestine are Wnt/β-catenin dependent.
Peron M; Dinarello A; Meneghetti G; Martorano L; Facchinello N; Vettori A; Licciardello G; Tiso N; Argenton F
Development; 2020 Jun; 147(12):. PubMed ID: 32467235
[TBL] [Abstract][Full Text] [Related]
19. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
20. IMU1003, an atrarate derivative, inhibits Wnt/β-catenin signaling.
Yonezawa H; Sugawara A; Sakyo T; Uehara Y; Kawano T; Nishiya N
Biochem Biophys Res Commun; 2020 Nov; 532(3):440-445. PubMed ID: 32891433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]